Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis

@article{Gorelik2018FluoroquinolonesAC,
  title={Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis},
  author={Einat Gorelik and Reem Masarwa and Amichai Perlman and Victoria Rotshild and Momen Abbasi and Mordechai Muszkat and Ilan Matok},
  journal={Drug Safety},
  year={2018},
  volume={42},
  pages={529-538}
}
IntroductionSeveral fluoroquinolone antibiotics have been associated with cardiac adverse effects, leading to the withdrawal of some of these agents from the market. Cardiac side effects such as QT prolongation and torsades de pointes (TdP) have also been observed with fluoroquinolones currently on the market. In order to evaluate the cardiac risk of fluoroquinolones as a class, and the comparative risk for each individual drug, we conducted a systematic review, meta-analysis, and network meta… 

Figures and Tables from this paper

How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones
TLDR
Moxifloxacin was found to be associated the most and ciprofloxac in the least with dysglycemia and fluoroquinolones must be used with great caution among diabetic patients who have comorbidities and are receiving antidiabetics and/or steroids.
Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self‐controlled case series analysis
TLDR
FQs were associated with an increase risk of AA/AD vs amoxicillin and azithromycin and an increased risk of all‐cause mortality vs multiple antibiotics commonly used for outpatient infections and should be limited to serious infections without appropriate alternatives.
Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data
TLDR
An impact on prescribing behaviour in response to regulatory safety warnings for two out of three warnings for fluoroquinolones is observed.
Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population‐Based Cohort Study
TLDR
Compared with first‐ or second‐generation cephalosporins, fluoroquinolones were not associated with increased risk of AA and AD in patients with UTI, however, a significant risk of mortality was still found in patients treated with fluoroquolones.
The safety of antimicrobials for the treatment of community-acquired pneumonia
TLDR
Overall, antimicrobials currently marketed for the treatment of CAP are well tolerated and generally safe, however, unusual and sometimes serious adverse effects can occur in susceptible populations.
Duration and Life-Stage of Antibiotic Use and Risks of All-Cause and Cause-Specific Mortality
TLDR
Long-term use of antibiotics in late adulthood may be a risk factor for all-cause and cardiovascular mortality in women and the unfavorable effect of antibiotic exposure for subsequent risks of deaths due to chronic diseases needs to be considered.
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
TLDR
No vaccine was statistically significantly associated with a decreased risk for severe COVID-19 than other vaccines, although mRNA-1273 and Gam-COVID-Vac have the highest P-scores, indicating greater protection against severe disease than other vaccine.
Inpatient Fluoroquinolone Stewardship Improves the Quantity and Quality of Fluoroquinolone-prescribing at Hospital Discharge: A Retrospective Analysis among 122 Veterans Health Administration Hospitals.
TLDR
The findings suggest that stewardship efforts to minimize and improve fluoroquinolone- Prescribing should also focus on antibiotic-prescribing at hospital discharge.
Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults
TLDR
It is suggested that zoliflodacin is not proarrhythmic and contribute to the favorable assessment of cardiac safety for a single oral dose of zol iflodacan, and this was a negative TQT study according to regulatory guidelines (E14).
Fluoroquinolones: Blessings Or Curses.
TLDR
The substantial progress of fluoroquinolones is reviewed from its discovery to black box warning to create a new and exciting era in antimicrobial treatment.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Fluoroquinolones increase the risk of serious arrhythmias
TLDR
The use of FQs could increase the risk of serious arrhythmias and CV death but not increase or all-cause death, and moxifloxacin and levofl Oxacin showed a higher risk ofserious arrh rhythmias.
Weighing the adverse cardiac effects of fluoroquinolones: A risk perspective
TLDR
A review of English‐language literature was performed to identify trials that provide data on the relative risk and, when able to be calculated, the incidence of adverse cardiac events among the commonly used FQs and found moxifloxacin had a several‐fold higher risk of cardiac arrhythmias than levofloxACin or ciprofloxacins in randomized trials.
Fluoroquinolones and the risk of serious arrhythmia: a population-based study.
TLDR
The use fluoroquinolones is associated with an elevated risk of serious arrhythmia, with some differences among molecules, which could inform the choice of different molecules in high-risk patients.
Effect of Macrolide and Fluoroquinolone Antibacterials on the Risk of Ventricular Arrhythmia and Cardiac Arrest
TLDR
Three observational study designs each using entirely different sets of controls consistently showed that recent use of macrolide and fluoro-quinolone antibacterials may be associated with increased risk of ventricular arrhythmia and cardiac arrest.
Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study
TLDR
Oral fluoroquinolone treatment was not associated with an increased risk of serious arrhythmia in the general adult populations of Denmark and Sweden and even small increases in relative and absolute risk could be ruled out.
Azithromycin and the risk of cardiovascular death.
TLDR
There was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease and patients in the highest decile of risk for cardiovascular disease.
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
TLDR
Healthcare professionals should consider the small but significant increased risk of ventricular arrhythmia and cardiovascular death when prescribing azithromycin and moxifloxacin when prescribing these antibiotics.
Arrhythmias associated with fluoroquinolone therapy.
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
TLDR
A retrospective cohort study among US veterans to test the hypothesis that taking azithromycin or levofloxacin would increase the risk of cardiovascular death and cardiac arrhythmia compared with persons taking amoxicillin, finding that it did so on days 1 to 5 but not 6 to 10.
Antibiotic-induced cardiac arrhythmias.
TLDR
The use of macrolides and fluoroquinolones antibiotics in the appropriate settings of infection should not be altered because of the rare risk of TdP, except among cases with high-risk factors.
...
1
2
3
4
...